/* ---- Google Analytics Code Below */

Wednesday, June 28, 2023

First Human Trials Begin for AI-Designed Drug

First Human Trials Begin for AI-Designed Drug

Story by The Daily Upside • Monday


or more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.

Forget college essays. Artificial intelligence has much bigger fish to fry.

Biotech firm Insilico Medicine said Monday that it entered an "AI-discovered-and-designed" drug into Phase 2 clinical trials involving human subjects, a first for the industry. The robots: they may not be so bad after all.

(Artificially) Intelligent Design

AI optimists have long pointed to advances in drug development as a reason for bullishness, and it's easy to understand why: The sheer data-crunching and protein-identifying prowess of such systems could potentially cut development time in half, and development prices by even more, proponents often claim. In plain English: AI can complete complex math problems far faster than human scientists ever could. Thus, AI and ML tools could help develop 50 new drugs worth potentially $50 billion over the next decade, according to a Morgan Stanley report.  ... ' 

No comments: